Literature DB >> 22907289

Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.

William P Arend1, Gary S Firestein.   

Abstract

Multiple proven and potential risk factors for the development of rheumatoid arthritis (RA) have been identified, and represent interactions between genes and the environment. Proven risk factors include genetic influences on the function of the innate and adaptive immune systems, smoking, anti-citrullinated protein antibodies (ACPAs), and rheumatoid factors (RF). Potential risk factors include epigenetic control of gene expression, the microbiome and other environmental factors, Toll-like receptors, cytokines, and Fc receptors. Preclinical abnormalities such as circulating RF and ACPAs may occur more than 10 years prior to the onset of clinical disease. However, the precise mechanisms whereby these risk factors lead to clinical disease remain unclear. It is possible that, combined with activation of the innate immune system, a subset of ACPAs initiates the disease in the cartilage or synovium after binding to endogenous citrullinated proteins. Subsequent engagement of Fc receptors and complement activation would lead to secondary inflammation in the synovium with induction of a perpetuating cycle of chronic synovitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907289     DOI: 10.1038/nrrheum.2012.134

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  181 in total

1.  Increased frequency of complement C4B deficiency in rheumatoid arthritis.

Authors:  William F C Rigby; Yee Ling Wu; Moe Zan; Bi Zhou; Sanna Rosengren; Cheryl Carlson; Whitney Hilton; C Yung Yu
Journal:  Arthritis Rheum       Date:  2012-05

Review 2.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.

Authors:  Yukinori Okada; Chikashi Terao; Katsunori Ikari; Yuta Kochi; Koichiro Ohmura; Akari Suzuki; Takahisa Kawaguchi; Eli A Stahl; Fina A S Kurreeman; Nao Nishida; Hiroko Ohmiya; Keiko Myouzen; Meiko Takahashi; Tetsuji Sawada; Yuichi Nishioka; Masao Yukioka; Tsukasa Matsubara; Shigeyuki Wakitani; Ryota Teshima; Shigeto Tohma; Kiyoshi Takasugi; Kota Shimada; Akira Murasawa; Shigeru Honjo; Keitaro Matsuo; Hideo Tanaka; Kazuo Tajima; Taku Suzuki; Takuji Iwamoto; Yoshiya Kawamura; Hisashi Tanii; Yuji Okazaki; Tsukasa Sasaki; Peter K Gregersen; Leonid Padyukov; Jane Worthington; Katherine A Siminovitch; Mark Lathrop; Atsuo Taniguchi; Atsushi Takahashi; Katsushi Tokunaga; Michiaki Kubo; Yusuke Nakamura; Naoyuki Kamatani; Tsuneyo Mimori; Robert M Plenge; Hisashi Yamanaka; Shigeki Momohara; Ryo Yamada; Fumihiko Matsuda; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

4.  Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Authors:  S P Linn-Rasker; A H M van der Helm-van Mil; F A van Gaalen; M Kloppenburg; R R P de Vries; S le Cessie; F C Breedveld; R E M Toes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

Review 5.  Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.

Authors:  Natalia Wegner; Karin Lundberg; Andrew Kinloch; Benjamin Fisher; Vivianne Malmström; Marc Feldmann; Patrick J Venables
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

6.  Particularities of the vasculature can promote the organ specificity of autoimmune attack.

Authors:  Bryce A Binstadt; Pratik R Patel; Herlen Alencar; Peter A Nigrovic; David M Lee; Umar Mahmood; Ralph Weissleder; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2006-01-29       Impact factor: 25.606

7.  Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.

Authors:  Ann W Morgan; Wendy Thomson; Stephen G Martin; Angela M Carter; Henry A Erlich; Anne Barton; Lynne Hocking; David M Reid; Pille Harrison; Paul Wordsworth; Sophia Steer; Jane Worthington; Paul Emery; Anthony G Wilson; Jennifer H Barrett
Journal:  Arthritis Rheum       Date:  2009-09

8.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

Review 9.  Rheumatoid arthritis and the complement system.

Authors:  Marcin Okroj; Dick Heinegård; Rikard Holmdahl; Anna M Blom
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

10.  Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay.

Authors:  Aleksander M Grabiec; Olexandr Korchynskyi; Paul P Tak; Kris A Reedquist
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

View more
  84 in total

Review 1.  Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?

Authors:  A M Mohamed Thoufic Ali; S Vino
Journal:  Rheumatol Int       Date:  2016-09-16       Impact factor: 2.631

2.  Elevated IgA Plasmablast Levels in Subjects at Risk of Developing Rheumatoid Arthritis.

Authors:  Jennifer D Kinslow; Lisa K Blum; Kevin D Deane; M Kristen Demoruelle; Yuko Okamoto; Mark C Parish; Sarah Kongpachith; Lauren J Lahey; Jill M Norris; William H Robinson; V Michael Holers
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

3.  Diagnostic uncertainty and epistemologic humility.

Authors:  Andrew Kelly; Richard S Panush
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

4.  Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.

Authors:  Nirmal K Banda; Gaurav Mehta; Viviana P Ferreira; Claudio Cortes; Matthew C Pickering; Michael K Pangburn; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2013-02-22       Impact factor: 5.422

5.  The preclinical phase of PsA: a challenge for the epidemiologist.

Authors:  Alexis Ogdie
Journal:  Ann Rheum Dis       Date:  2017-03-08       Impact factor: 19.103

Review 6.  [Immunology of systemic inflammatory diseases].

Authors:  M Aringer; H Schulze-Koops
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

Review 7.  Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.

Authors:  V Michael Holers
Journal:  Curr Opin Immunol       Date:  2013-11-08       Impact factor: 7.486

Review 8.  Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?

Authors:  Jose U Scher; Walter A Bretz; Steven B Abramson
Journal:  Curr Opin Rheumatol       Date:  2014-07       Impact factor: 5.006

Review 9.  Does lipopolysaccharide-mediated inflammation have a role in OA?

Authors:  Zeyu Huang; Virginia Byers Kraus
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 10.  Autoantibodies and SLE: the threshold for disease.

Authors:  Nancy J Olsen; David R Karp
Journal:  Nat Rev Rheumatol       Date:  2013-12-03       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.